{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:14:58Z","timestamp":1770819298211,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00120-025-02745-9","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:59:14Z","timestamp":1768298354000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Palliativmedizin und integrative Medizin erg\u00e4nzend in der uroonkologischen Behandlung","Palliative medicine and integrative medicine as complementary approaches in uro-oncological care"],"prefix":"10.1007","volume":"65","author":[{"given":"Petra","family":"Klose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Voi\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martje","family":"Voswinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Reumkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"3","key":"2745_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12312-020-00792-1","volume":"35","author":"B Alt-Epping","year":"2020","unstructured":"Alt-Epping\u00a0B (2020) Fr\u00fchzeitige Integration von Palliativmedizin. Forum 35(3):206\u2013211","journal-title":"Forum"},{"issue":"2","key":"2745_CR2","first-page":"24","volume":"1","author":"M Beintker","year":"2019","unstructured":"Beintker\u00a0M (2019) Palliativmedizin: Uroonkologie im palliativen Setting. UroForum 1(2):24\u201325","journal-title":"UroForum"},{"key":"2745_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s15015-025-4247-5","volume":"28","author":"P Blickle","year":"2025","unstructured":"Blickle\u00a0P, Schmidt\u00a0M, Steindorf\u00a0K (2025) Erfassung und Behandlung krebsassoziierter Fatigue. Fokus Onkol 28:70\u201374","journal-title":"Fokus Onkol"},{"issue":"20","key":"2745_CR4","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1200\/JCO.24.00541","volume":"42","author":"JE Bower","year":"2024","unstructured":"Bower\u00a0JE, Lacchetti\u00a0C, Alici\u00a0Y et\u00a0al (2024) Management of fatigue in adult survivors of cancer: aSCO-society for integrative oncology guideline update. J\u00a0Clin Oncol 42(20):2456\u20132487","journal-title":"J Clin Oncol"},{"issue":"10","key":"2745_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1200\/OP.23.00358","volume":"19","author":"LE Carlson","year":"2023","unstructured":"Carlson\u00a0LE, Ismaila\u00a0N, Addington\u00a0EL et\u00a0al (2023) Integrative oncology care of symptoms of anxiety and depression in adults with cancer: SIO-ASCO guideline summary and Q&A. JCO Oncol Pract 19(10):847\u2013851","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"2745_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5534\/wjmh.230319","volume":"43","author":"DRH Christie","year":"2025","unstructured":"Christie\u00a0DRH, Sharpley\u00a0CF, Bitsika\u00a0V (2025) A systematic review of the association between psychological resilience and improved psychosocial outcomes in prostate cancer patients: could resilience training have a\u00a0potential role? World J Mens Health 43(1):70\u201380","journal-title":"World J Mens Health"},{"issue":"20","key":"2745_CR7","first-page":"18","volume":"119","author":"A Dinkel","year":"2022","unstructured":"Dinkel\u00a0A (2022) Perspektiven in der Onkoloie: Progredienzangst in der onkologischen Praxis: Kurzinterventionen k\u00f6nnen die Lebensqualit\u00e4t steigern. Dtsch \u00c4rztebl 119(20):18","journal-title":"Dtsch \u00c4rztebl"},{"issue":"3","key":"2745_CR8","doi-asserted-by":"publisher","first-page":"e0193686","DOI":"10.1371\/journal.pone.0193686","volume":"13","author":"S Egger","year":"2018","unstructured":"Egger\u00a0S, Hughes\u00a0S, Smith\u00a0DP et\u00a0al (2018) Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors. PLoS ONE 13(3):e193686","journal-title":"PLoS ONE"},{"issue":"6","key":"2745_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","volume":"31","author":"A Fabi","year":"2020","unstructured":"Fabi\u00a0A, Bhargava\u00a0R, Fatigoni\u00a0S et\u00a0al (2020) Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol 31(6):713\u2013723","journal-title":"Ann Oncol"},{"issue":"3","key":"2745_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1200\/JCO.2017.75.6288","volume":"36","author":"JJ Fenton","year":"2018","unstructured":"Fenton\u00a0JJ, Duberstein\u00a0PR, Kravitz\u00a0RL et\u00a0al (2018) Impact of prognostic discussions on the patient-physician relationship: prospective cohort study. J\u00a0Clin Oncol 36(3):225\u2013230","journal-title":"J Clin Oncol"},{"issue":"4","key":"2745_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.euo.2019.06.020","volume":"4","author":"AS Friberg","year":"2021","unstructured":"Friberg\u00a0AS, Dalton\u00a0SO, Larsen\u00a0SB et\u00a0al (2021) Risk of depression after radical prostatectomy\u2014a nationwide registry-based study. Eur Urol Oncol 4(4):601\u2013608","journal-title":"Eur Urol Oncol"},{"key":"2745_CR12","volume-title":"Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"WHO","year":"2019","unstructured":"WHO (2019) Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents"},{"key":"2745_CR13","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.ctim.2020.102344","volume":"50","author":"M Harorani","year":"2020","unstructured":"Harorani\u00a0M, Davodabady\u00a0F, Farahani\u00a0Z et\u00a0al (2020) The effect of Benson\u2019s relaxation response on sleep quality and anorexia in cancer patients undergoing chemotherapy: a\u00a0randomized controlled trial. Complement Ther Med 50:102344","journal-title":"Complement Ther Med"},{"key":"2745_CR14","volume-title":"DGS-Praxisleitlinien Schmerzmedizin","author":"J Horleman","year":"2025","unstructured":"Horleman\u00a0J, Sch\u00fcrmann\u00a0N (2025) DGS-Praxisleitlinien Schmerzmedizin"},{"issue":"7","key":"2745_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1634\/theoncologist.2016-0006","volume":"21","author":"D Hui","year":"2016","unstructured":"Hui\u00a0D, Meng\u00a0YC, Bruera\u00a0S et\u00a0al (2016) Referral criteria for outpatient palliative cancer care: a\u00a0systematic review. Oncologist 21(7):895\u2013901","journal-title":"Oncologist"},{"issue":"6","key":"2745_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.eururo.2023.02.009","volume":"83","author":"GRR Ilie","year":"2023","unstructured":"Ilie\u00a0GRR, Mason\u00a0R, MacDonald\u00a0C, Kucharczyk\u00a0MJ, Patil\u00a0N, Bowes\u00a0D, Bailly\u00a0G, Bell\u00a0D, Lawen\u00a0J, Ha\u00a0M, Wilke\u00a0D, Massaro\u00a0P, Zahavich\u00a0J, Kephart\u00a0G, Rutledge\u00a0RDH (2023) A comprehensive 6\u2011mo prostate cancer patient empowerment program decreases psychological distress among men undergoing curative prostate cancer treatment: a\u00a0randomized clinical trial. Eur Urol 83(6):551\u2013570","journal-title":"Eur Urol"},{"key":"2745_CR17","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1017\/S0140525X1400082X","volume":"38","author":"R Kalisch","year":"2015","unstructured":"Kalisch\u00a0R, Muller\u00a0MB, Tuscher\u00a0O (2015) A conceptual framework for the neurobiological study of resilience. Behav Brain Sci 38:e92","journal-title":"Behav Brain Sci"},{"issue":"1","key":"2745_CR18","doi-asserted-by":"publisher","first-page":"12815","DOI":"10.1038\/s41598-023-39046-0","volume":"13","author":"YE Kang","year":"2023","unstructured":"Kang\u00a0YE, Yoon\u00a0JH, Park\u00a0NH et\u00a0al (2023) Prevalence of cancer-related fatigue based on severity: a\u00a0systematic review and meta-analysis. Sci Rep 13(1):12815","journal-title":"Sci Rep"},{"key":"2745_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ctcp.2019.01.004","volume":"35","author":"MR Keene","year":"2019","unstructured":"Keene\u00a0MR, Heslop\u00a0IM, Sabesan\u00a0SS et\u00a0al (2019) Complementary and alternative medicine use in cancer: a\u00a0systematic review. Complement Ther Clin Pract 35:33\u201347","journal-title":"Complement Ther Clin Pract"},{"key":"2745_CR20","first-page":"40","volume":"10","author":"P Kirschner","year":"2022","unstructured":"Kirschner\u00a0P (2022) Palliativmedizin-Herausforderung des Alltags. UroForum 10:40\u201341","journal-title":"UroForum"},{"issue":"7","key":"2745_CR21","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.pec.2015.02.018","volume":"98","author":"CJ Koenig","year":"2015","unstructured":"Koenig\u00a0CJ, Ho\u00a0EY, Trupin\u00a0L et\u00a0al (2015) An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits. Patient Educ Couns 98(7):857\u2013863","journal-title":"Patient Educ Couns"},{"key":"2745_CR22","first-page":"865","volume":"51\u201352","author":"P Ludolph","year":"2019","unstructured":"Ludolph\u00a0P, Kunzler\u00a0AM, Stoffers-Winterling\u00a0J et\u00a0al (2019) Interventions to promote resilience in cancer patients. Dtsch \u00c4rztebl Int 51\u201352:865\u2013872","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"34","key":"2745_CR23","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1200\/JCO.22.01357","volume":"40","author":"JJ Mao","year":"2022","unstructured":"Mao\u00a0JJ, Ismaila\u00a0N, Bao\u00a0T et\u00a0al (2022) Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J\u00a0Clin Oncol 40(34):3998\u20134024","journal-title":"J Clin Oncol"},{"key":"2745_CR24","first-page":"2","volume":"4","author":"E Masel","year":"2022","unstructured":"Masel\u00a0E (2022) Palliative care statt palliate scare. Spectr Urol 4:2\u20134","journal-title":"Spectr Urol"},{"issue":"6","key":"2745_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/bju.16288","volume":"133","author":"J Maurer","year":"2024","unstructured":"Maurer\u00a0J, Friedemann\u00a0T, Chen\u00a0Y et\u00a0al (2024) A randomized controlled study on acupuncture for peri-operative pain after open radical prostatectomy. BJU Int 133(6):725\u2013732","journal-title":"BJU Int"},{"key":"2745_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-0042-118765","volume":"17","author":"A Mehnert","year":"2016","unstructured":"Mehnert\u00a0A, Nauck\u00a0F (2016) Psychotherapie in der palliativen Versorgung. Z\u00a0Palliativmed 17:289\u2013301","journal-title":"Z Palliativmed"},{"issue":"6","key":"2745_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken\u00a0MM, Creech\u00a0RH, Tormey\u00a0DC et\u00a0al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"2745_CR28","volume-title":"S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms","author":"Deutsche Krebsgesellschaft","year":"2025","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2025) S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms"},{"key":"2745_CR29","volume-title":"S3-Leitlinie Komplement\u00e4rmedizin in der Behandlung von onkologischen PatientInnen","author":"Deutsche Krebsgesellschaft","year":"2024","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2024) S3-Leitlinie Komplement\u00e4rmedizin in der Behandlung von onkologischen PatientInnen"},{"key":"2745_CR30","volume-title":"S3-Leitlinie Prostatakarzinom","author":"Deutsche Krebsgesellschaft","year":"2025","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2025) S3-Leitlinie Prostatakarzinom"},{"key":"2745_CR31","unstructured":"Palliativmedizin f\u00fcr Patienten mit einer nicht-heilbaren Krebserkrankung [Internet]. 2020 [cited 30.10.2025]."},{"issue":"6","key":"2745_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.urpr.2017.11.001","volume":"5","author":"SC Pannell","year":"2018","unstructured":"Pannell\u00a0SC, Laviana\u00a0AA, Huen\u00a0KHY et\u00a0al (2018) Advance care planning and patient preferences in a\u00a0feasibility pilot study to improve end-of-life communication among men with metastatic urological malignancies. Urol Pract 5(6):421\u2013426","journal-title":"Urol Pract"},{"issue":"8","key":"2745_CR33","first-page":"6405","volume":"30","author":"F Pelzer","year":"2022","unstructured":"Pelzer\u00a0F, Loef\u00a0M, Martin\u00a0DD et\u00a0al (2022) Cancer-related fatigue in patients treated with mistletoe extracts: a\u00a0systematic review and meta-analysis. Support Care Cancer 30(8):6405\u20136418","journal-title":"Support Care Cancer"},{"key":"2745_CR34","first-page":"1023","volume":"9","author":"J Polanski","year":"2016","unstructured":"Polanski\u00a0J, Jankowska-Polanska\u00a0B, Rosinczuk\u00a0J et\u00a0al (2016) Quality of life of patients with lung cancer. Onco Targets Ther 9:1023\u20131028","journal-title":"Onco Targets Ther"},{"issue":"8","key":"2745_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.6004\/jnccn.2023.0041","volume":"21","author":"T Sanft","year":"2023","unstructured":"Sanft\u00a0T, Day\u00a0A, Ansbaugh\u00a0S et\u00a0al (2023) NCCN guidelines(R) insights: survivorship, version 1.2023. J\u00a0Natl Compr Canc Netw 21(8):792\u2013803","journal-title":"J Natl Compr Canc Netw"},{"key":"2745_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/15579883211001201","author":"CF Sharpley","year":"2021","unstructured":"Sharpley\u00a0CF, Christie\u00a0DRH, Bitsika\u00a0V (2021) Deterioration in sleep quality affects cognitive depression in prostate cancer patients. Am J Mens Health. https:\/\/doi.org\/10.1177\/15579883211001201","journal-title":"Am J Mens Health"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-025-02745-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:29:14Z","timestamp":1770816554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-025-02745-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2745"],"URL":"https:\/\/doi.org\/10.1007\/s00120-025-02745-9","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Klose, M.\u00a0Voswinkel und E.\u00a0Reumkens geben an, dass kein Interessenkonflikt besteht. P.\u00a0Voi\u00df gibt folgende Interessenkonflikte an: Vortragst\u00e4tigkeit: Novartis, Pfizer, Roche, Seagen, Lilly, Gilead, Amgen, Bristol-Myers Squibb, Helixor. Beratert\u00e4tigkeit: WALA, Novartis. Forschungsf\u00f6rderung durch die Karl und Veronica Carstens Stiftung und Karl-Heinz Frenzen-Stiftung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}